The KEGG results revealed that the DEGs between the low- and high-risk groups were mainly enriched in bladder cancer, complement and coagulation cascades, ECM-receptor interaction, arachidonic acid pathway, and IL-17 signaling pathway. The gene discussed is IL17A; the disease is urinary bladder carcinoma.